The J.M. Smucker Company
SJM
$119.41
+3.00%
The J.M. Smucker Company is a packaged foods manufacturer whose portfolio spans retail coffee (Folgers, Dunkin', Cafe Bustelo), pet foods (Milk-Bone, Meow Mix), frozen handhelds and spreads (Jif, Smucker's, Uncrustables), and sweet baked snacks following the Hostess Brands acquisition, with roughly 75% of fiscal 2026 revenue generated through the U.S. retail channel. As a mature, dividend-paying consumer staples operator with approximately 8,000 employees, Smucker is best characterized as a brand-portfolio consolidator rather than a growth disruptor, competing on shelf presence, pricing power, and cost discipline against peers like Kraft Heinz, General Mills, and Conagra. The current investor debate centers on whether coffee pricing actions can offset volume softness and whether the Hostess acquisition can stabilize a sweet baked snacks franchise that has faced integration and demand challenges, while a large non-cash impairment in the January 2026 quarter (driving a $724 million net loss) has muddied trailing profitability optics. Recent headlines highlight that higher coffee prices delivered a Q4 earnings beat, but management's weak forward sales outlook has tempered the bull case, leaving investors weighing margin resilience against top-line stagnation.…
SJM
The J.M. Smucker Company
$119.41
Related headlines
Investment Opinion: Should I buy SJM Today?
SJM is rated a Hold with a balanced risk/reward profile: the analyst consensus is 'buy' with an average target of $142.13 (21.3% upside), but the weak forward sales outlook and recent 10.84% monthly decline warrant caution. The core thesis is that the stock is deeply undervalued on a forward PE of 10.73x and PS of 1.16x, but lacks a near-term catalyst to close the gap until revenue growth inflects. The 4.44% dividend yield and low beta of 0.263 provide defensive support, making it suitable for income-oriented investors.
Supporting evidence includes: (1) forward PE of 10.73x versus peers at 15–20x, a 30–45% discount; (2) trailing free cash flow of $1.588 billion covering the dividend; (3) operating margin of 23.05% in the latest quarter, showing underlying profitability; and (4) analyst target upside of 21.3% with no sell ratings. The PEG ratio of 0.85 further suggests the stock is cheap relative to expected growth. However, revenue growth of 5.02% YoY is modest and driven by pricing, not volume, and the Hostess integration remains a wildcard.
Key risks that could invalidate the thesis include a continued decline in coffee volumes, failure to stabilize Hostess, and elevated leverage (debt-to-equity of 1.28). The rating would upgrade to Buy if revenue growth accelerates above 7% or if the stock breaks above $132 resistance, and downgrade to Sell if revenue growth turns negative or if free cash flow falls below $1.2 billion. Relative to its own history (forward PE of 10.73x vs. historical 12x–33x) and peers, SJM appears undervalued, but the discount is partially justified by weak growth and integration risks.
Sign up to view all
SJM 12-Month Price Forecast
SJM presents a balanced risk/reward: the deep valuation discount and strong cash flow generation are offset by weak forward sales guidance and integration risks. The stock's low beta of 0.263 and 4.44% dividend yield make it a defensive holding, but the recent 10.84% monthly decline and 11.43 percentage point underperformance versus SPY highlight near-term headwinds. I would upgrade to bullish if revenue growth accelerates above 5% with volume gains, or downgrade to bearish if free cash flow falls below $1.2 billion or the dividend is cut. The base case (55% probability) targets $120–$142, implying a total return of 2–21% over 12 months.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on The J.M. Smucker Company's 12-month outlook, with a consensus price target around $142.13 and implied upside of +19.0% versus the current price.
Average Target
$142.13
0 analysts
Implied Upside
+19.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$120 - $157
Analyst target range
Coverage is solid with 16 analysts, and sentiment leans bullish: the consensus recommendation is "buy" with a recommendation mean of 2.11 (where lower is more bullish), and the average target price of $142.13 implies approximately 21.3% upside from the current price of $117.19. The Buy/Hold/Sell distribution from recent institutional ratings shows a clear bullish tilt — Outperform/Buy/Overweight ratings from RBC Capital, Wells Fargo, Evercore ISI, Bernstein, UBS, Jefferies, and JP Morgan, versus Equal Weight/Hold from Barclays and TD Cowen — with no sell ratings, indicating analysts see the recent pullback as a buying opportunity rather than a deterioration in fundamentals.
The target range spans $120.00 to $157.00, a spread of $37 (roughly 31% of the low target), which signals moderate-to-high uncertainty. The high target of $157 assumes successful coffee pricing flow-through, Hostess stabilization, and multiple expansion toward historical norms, while the low target of $120 — barely above the current price — prices in continued volume weakness and margin compression. Notably, all recent rating actions (August 2026) were reiterations rather than upgrades or downgrades, suggesting analysts are in a holding pattern awaiting evidence that the forward sales outlook improves; the tight clustering of estimates (EPS range of $11.37–$12.29) indicates strong conviction on near-term earnings but wide disagreement on the appropriate multiple, making the stock's re-rating dependent on revenue inflection rather than cost control alone.
Bulls vs Bears: SJM Investment Factors
The bear case currently has stronger near-term evidence due to the weak forward sales outlook, recent 10.84% monthly decline, and elevated leverage, but the bull case is supported by deep valuation discounts, robust free cash flow, and a unanimous analyst buy consensus with 21.3% upside. The single most important tension is whether coffee pricing actions can offset volume softness and drive a revenue inflection — if they do, the stock could re-rate toward historical multiples; if not, the discount may persist. The low beta of 0.263 and 4.44% dividend yield provide defensive support, but the Hostess integration and impairment overhang add uncertainty. Ultimately, the resolution of the revenue trajectory will determine whether SJM is a value trap or a compelling turnaround.
Bullish
- Deep Valuation Discount to Peers: SJM trades at a forward PE of 10.73x and PS of 1.16x, versus typical packaged foods peers at 15–20x forward earnings and 1.5–2.5x sales — a roughly 30–45% earnings discount. The PEG ratio of 0.85 (below 1.0) suggests the stock is inexpensive relative to expected growth, and the PB of 1.89x sits near the low end of its multi-year 1.58x–2.27x band.
- Strong Free Cash Flow and Dividend Coverage: Trailing free cash flow is $1.588 billion, with the latest quarter generating $425.7 million in operating cash flow and $337.3 million in FCF after $88.4 million in capex. This comfortably covers the $116.8 million quarterly dividend, supporting a 4.44% dividend yield that is well-covered despite a negative payout ratio from impairment-driven GAAP losses.
- Analyst Consensus Buy with 21% Upside: 16 analysts rate SJM a 'buy' with a recommendation mean of 2.11 and an average target price of $142.13, implying 21.3% upside from the current $117.19. The distribution is bullish — Outperform/Buy/Overweight from RBC, Wells Fargo, Evercore ISI, Bernstein, UBS, Jefferies, and JP Morgan — with no sell ratings.
- Operating Margin Resilience Despite Impairments: The latest quarter posted a 23.05% operating margin and 44.14% gross margin, with EBITDA of $637.7 million (28.73% EBITDA margin). These underlying metrics demonstrate pricing power and cost discipline, even as trailing margins are distorted by a $1.07 billion non-cash charge in the January 2026 quarter.
Bearish
- Weak Forward Sales Outlook: Management's weak forward sales guidance has tempered the bull case, with consensus revenue estimate of $9.27 billion implying decelerating growth. The most recent quarter's 5.02% YoY revenue growth was driven largely by coffee pricing actions rather than volume, and a top-line stagnation would cap multiple expansion.
- Recent Sharp Underperformance: SJM is down 10.84% over the past month, trailing SPY by 11.43 percentage points, an unusually large drawdown for a low-beta defensive name. This suggests stock-specific disappointment rather than market-wide risk aversion, and the failure to hold the August peak near $132 signals heavy overhead supply.
- Elevated Leverage and Thin Liquidity: Debt-to-equity stands at 1.28, the current ratio is a thin 0.78, and cash on hand is just $43.2 million against $230.8 million in quarterly debt repayment. This reliance on consistent operating cash flow leaves little room for error if coffee input costs spike or volumes deteriorate further.
- Hostess Integration and Demand Risk: The Hostess Brands acquisition has faced integration and demand challenges, with Sweet Baked Snacks generating only $236.5 million in segment revenue — the smallest of the four segments. Stabilizing this franchise is critical to the growth story, but execution risk remains high.
SJM Technical Analysis
SJM is in a recovery uptrend that has stalled near the top of its range: the stock is up 8.71% over the past year and 21.28% year-to-date, trading at roughly 57% of its 52-week range (52-week low of $88.25, high of $135.89) with a current price of $117.19. That positioning — well above the lows but about 14% below the high — suggests the stock has reclaimed its footing after a difficult stretch but lacks the momentum to challenge prior highs, a classic mid-range consolidation posture for a defensive name. The 22.75% six-month gain confirms a genuine trend improvement off the lows, though the failure to hold the August peak near $132 signals overhead supply remains heavy.
Short-term momentum has turned decisively negative and diverges sharply from the longer-term trend: SJM is down 10.84% over the past month while still up 8.71% over twelve months and 0.78% over three months, meaning the recent pullback has erased most of the summer rally's gains. Relative strength tells the same story — SJM trails SPY by 11.43 percentage points over one month and 6.30 points over one year, though it still leads SPY by 8.42 points year-to-date, indicating the underperformance is a recent phenomenon rather than a chronic trend. With a beta of just 0.263, this is a low-volatility defensive name where a 10.8% monthly drawdown is unusually large and likely reflects stock-specific disappointment (weak forward sales guidance) rather than market-wide risk aversion.
Key technical levels are clearly defined: support sits at the 52-week low of $88.25, with intermediate support around the $115–$117 area where the stock is currently stabilizing, while resistance is anchored at the 52-week high of $135.89 and the August swing high near $132. A breakout above $132–$136 would signal renewed institutional accumulation and open the door to a re-rating, whereas a breakdown below $115 would put the $100–$105 zone in play and likely confirm the one-month downtrend as the dominant trend. The beta of 0.263 implies roughly 74% less volatility than SPY, which supports larger position sizing for risk-parity investors but also means the stock's recent 10.8% monthly decline is a meaningful outlier worth monitoring; the short ratio of 3.37 suggests short sellers are not aggressively positioned, limiting squeeze potential but also indicating no extreme bearish conviction.
Beta
0.27
0.27x market volatility
Max Drawdown
-22.8%
Largest decline past year
52-Week Range
$88-$136
Price range past year
Annual Return
+12.7%
Cumulative gain past year
| Period | SJM Return | S&P 500 |
|---|---|---|
| 1m | -4.2% | +1.0% |
| 3m | +7.0% | +2.5% |
| 6m | +31.3% | +13.9% |
| 1y | +12.7% | +15.0% |
| ytd | +23.6% | +13.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SJM Fundamental Analysis
Revenue is growing modestly but the trajectory is uneven: the most recent quarter (ending 2026-07-31) delivered $2.219 billion in revenue, up 5.02% year-over-year, following $2.268 billion in the April 2026 quarter and $2.339 billion in the January 2026 quarter. Segment data shows U.S. Retail Coffee is the dominant engine at $916.8 million, followed by U.S. Retail Consumer Foods at $499.3 million, U.S. Retail Pet Foods at $371.7 million, and Sweet Baked Snacks at $236.5 million — meaning coffee alone represents over 40% of segment revenue and is the primary swing factor for the growth story. The 5% YoY growth is respectable for packaged foods but is driven largely by coffee pricing actions rather than volume, and management's weak forward sales outlook (consensus revenue estimate of $9.27 billion) implies growth is decelerating, which caps multiple expansion potential.
Profitability is strong at the operating level but distorted at the net level by impairments: the latest quarter posted $324.3 million in net income on a 44.14% gross margin and 23.05% operating margin, a dramatic improvement from the January 2026 quarter's $724.2 million net loss (driven by a $1.07 billion non-cash other-expense charge) and the year-ago quarter's $43.9 million loss. Gross margin has been volatile — 44.14% in the July 2026 quarter versus 38.01% in April 2026 and 35.39% in January 2026 — but the trailing gross margin of 33.53% and operating margin of 14.84% reflect the impairment drag; the underlying business generates EBITDA of $637.7 million in the latest quarter with a healthy 28.73% EBITDA margin. The net margin of -1.53% and negative EPS of -$0.013 are artifacts of one-time charges, not operational weakness, and the forward EPS estimate of $12.08 implies the market expects clean profitability to resume.
Balance sheet and cash flow metrics reveal a leveraged but cash-generative business: debt-to-equity stands at 1.28, the current ratio is a thin 0.78, and cash on hand is just $43.2 million against $230.8 million in quarterly debt repayment, highlighting the company's reliance on consistent operating cash flow. Free cash flow is robust at $1.588 billion on a trailing basis, with the latest quarter generating $425.7 million in operating cash flow and $337.3 million in FCF after $88.4 million in capex, comfortably covering the $116.8 million quarterly dividend. However, ROE is negative at -2.50% (impairment-driven) while ROA is a positive 6.26%, and the 4.44% dividend yield is well-covered by FCF but leaves little room for error if coffee input costs spike or volumes deteriorate further.
Quarterly Revenue
$2.2B
2026-07
Revenue YoY Growth
+5.0%
YoY Comparison
Gross Margin
44.1%
Latest Quarter
Free Cash Flow
$1.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SJM Overvalued?
Because trailing net income is negative (EPS of -$0.013, trailing PE of -75.4x), the PE ratio is not meaningful; I am therefore leading with the forward PE of 10.73x and the PS ratio of 1.16x as the primary valuation anchors. The forward PE of 10.73x against a trailing PE that is negative due to impairments implies the market expects a sharp earnings recovery to roughly $12.08 per share, and the PEG ratio of 0.85 (below 1.0) suggests the stock is inexpensive relative to expected growth. The EV/EBITDA of 19.97x, however, appears elevated for a packaged foods company and likely reflects the depressed trailing EBITDA base caused by impairments.
On a peer basis, SJM's PS ratio of 1.16x and forward PE of 10.73x sit at a discount to typical packaged foods valuations — large-cap staples peers often trade at 15–20x forward earnings and 1.5–2.5x sales — implying a roughly 30–45% discount on earnings and a meaningful discount on sales. The PB ratio of 1.89x is modest, and the EV/Sales of 2.11x is reasonable for a branded food company with leading category positions. This discount appears partially justified by the company's weak organic growth, Hostess integration risk, and elevated leverage (debt-to-equity of 1.28), but the 4.44% dividend yield and 0.85 PEG suggest the market may be overly punitive given the company's stable cash generation.
Historically, SJM's PS ratio has ranged from roughly 4.6x to 8.5x over the past several years (per historical ratios data), but the current reported PS of 1.16x reflects a different share-count/market-cap basis and is not directly comparable; using the historical series' own scale, the stock's PS has compressed from ~5.7x in mid-2026 to lower levels, and the PB ratio of 1.89x is near the low end of its multi-year 1.58x–2.27x band. The forward PE of 10.73x is well below the historical PE readings of 12x–33x seen in profitable quarters over the past three years, suggesting the stock trades near the bottom of its own valuation band. This implies the market is pricing in pessimistic expectations — either that earnings recovery stalls or that the impairment reflects deeper portfolio issues — creating potential value opportunity if execution stabilizes, but also signaling genuine fundamental concern rather than mere sentiment.
PE
-75.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 7x~33x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
20.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant: SJM carries a debt-to-equity of 1.28 and a thin current ratio of 0.78, with only $43.2 million in cash against $230.8 million in quarterly debt repayment, leaving little liquidity buffer. The company's 4.44% dividend yield, while covered by $1.588 billion in trailing free cash flow, consumes $116.8 million quarterly and could be at risk if coffee input costs spike or volumes decline. Additionally, revenue concentration is high — U.S. Retail Coffee alone represents over 40% of segment revenue at $916.8 million, making the entire growth story dependent on pricing actions in a single category. The January 2026 impairment of $1.07 billion also highlights the risk of further write-downs if portfolio brands underperform.
Market and competitive risks include valuation compression if SJM fails to meet growth expectations, given its forward PE of 10.73x already reflects a discount to peers but could contract further if revenue stagnates. The stock's low beta of 0.263 means it is less sensitive to market swings, but its recent 10.84% monthly decline shows it is not immune to stock-specific shocks, such as weak guidance. Competitive pressures from Kraft Heinz, General Mills, and Conagra are intense, and Conagra's recent 52-week low and CEO transition underscore the challenges in packaged foods. Regulatory headwinds, such as changing consumer preferences toward healthier options, could also pressure traditional brands like Folgers and Jif.
In a worst-case scenario, a continued decline in coffee volumes, failure to stabilize Hostess, and a broader sector rotation away from staples could drive SJM toward its 52-week low of $88.25, representing a 24.7% downside from the current $117.19. The analyst low target of $120 is only 2.4% above the current price, suggesting limited downside protection if fundamentals deteriorate. A breakdown below the $115 support level would likely put the $100–$105 zone in play, and a more severe scenario could see the stock test the 52-week low, implying a loss of roughly 25% from current levels. The max drawdown of -22.82% over the past year further illustrates the potential magnitude of a downturn.
FAQ
The most severe risk is financial: debt-to-equity of 1.28 and a thin current ratio of 0.78 leave little liquidity buffer, and a dividend cut could occur if free cash flow (currently $1.588 billion) falls below $1.2 billion. Competitive risks include intense pressure from Kraft Heinz, General Mills, and Conagra, as well as changing consumer preferences away from traditional brands like Folgers and Jif. Macro risks are moderate given the low beta of 0.263, but a sector rotation out of staples could compress the multiple further. Company-specific risks include the Hostess integration, which has faced demand challenges, and the potential for further impairments after the $1.07 billion charge in January 2026.
Our 12-month forecast has three scenarios: a base case (55% probability) targeting $120–$142, assuming modest revenue growth and stable margins; a bull case (25% probability) targeting $142–$157, driven by successful coffee pricing and Hostess stabilization; and a bear case (20% probability) targeting $88–$120, if volume weakness persists and margins compress. The most likely scenario is the base case, with the key assumption that revenue grows 3–5% annually and free cash flow remains above $1.5 billion. The analyst average target of $142.13 aligns with the base case, implying 21.3% upside from the current $117.19.
SJM appears undervalued on both absolute and relative bases. Its forward PE of 10.73x is well below the historical range of 12x–33x and significantly below the 15–20x typical for large-cap packaged foods peers. The PS ratio of 1.16x and PB of 1.89x are also at the low end of their multi-year ranges, while the PEG ratio of 0.85 suggests the stock is cheap relative to expected growth. However, the discount is partially justified by weak organic growth, Hostess integration risk, and elevated leverage (debt-to-equity of 1.28). The market is pricing in pessimistic expectations, creating potential value if execution stabilizes, but also signaling genuine fundamental concerns.
SJM offers a compelling risk/reward for value and income investors: it trades at a forward PE of 10.73x, a 30–45% discount to packaged foods peers, with a 4.44% dividend yield and 21.3% upside to the analyst average target of $142.13. However, the weak forward sales outlook and recent 10.84% monthly decline suggest near-term headwinds, and the Hostess integration remains uncertain. The stock is best suited for patient investors who can tolerate volatility and are attracted to the defensive, low-beta (0.263) profile. A good entry point would be near the $115 support level, with a stop-loss below $110 to manage downside risk. Overall, it is a moderate buy for income-focused portfolios, but not a high-growth opportunity.
SJM is best suited for long-term investment, given its defensive characteristics, low beta of 0.263, and 4.44% dividend yield. The stock is in a mature stage with modest growth prospects, and its earnings visibility is moderate, making it less attractive for short-term trading. The recent 10.84% monthly decline and 11.43 percentage point underperformance versus SPY highlight near-term volatility, but the long-term trend is positive (up 21.28% YTD). A suggested minimum holding period is 2–3 years to allow for Hostess integration and potential multiple expansion. Short-term traders could exploit the $115–$132 range, but the low beta limits explosive moves.